Drug-Related Side Effects and Adverse Reactions

Prenatal use of antiepileptic drugs and childhood psychiatric disorders
Drug and Therapeutics Bulletin Apr 2024, dtb-2024-000026; DOI: 10.1136/dtb.2024.000026
Donanemab in early symptomatic Alzheimer’s disease
Drug and Therapeutics Bulletin May 2024, 62 (5) 67; DOI: 10.1136/dtb.2024.000020
Recent updates from the BNF (BNF 87)
Drug and Therapeutics Bulletin May 2024, 62 (5) 68-70; DOI: 10.1136/dtb.2024.000018
MHRA issues further update on fluoroquinolone safety
Drug and Therapeutics Bulletin Apr 2024, dtb-2024-000021; DOI: 10.1136/dtb.2024.000021
Use of oral penicillin challenge in low-risk penicillin allergy
Drug and Therapeutics Bulletin Apr 2024, 62 (4) 51; DOI: 10.1136/dtb.2024.000015
Does oseltamivir prevent hospitalisation in people with influenza?
Drug and Therapeutics Bulletin Apr 2024, 62 (4) 52; DOI: 10.1136/dtb.2024.000016
Effect of topical testosterone on pre-diabetes and diabetes
Drug and Therapeutics Bulletin Apr 2024, 62 (4) 54; DOI: 10.1136/dtb.2024.000017
Safety update: valproate safety and educational materials
Drug and Therapeutics Bulletin Apr 2024, 62 (4) 53; DOI: 10.1136/dtb.2024.000013
Do regulatory safety warnings on medicines miss the mark?
Barbara Mintzes

Drug and Therapeutics Bulletin Apr 2024, 62 (4) 50; DOI: 10.1136/dtb.2023.000053
Effect of semaglutide on major cardiovascular events
Drug and Therapeutics Bulletin Mar 2024, 62 (3) 35; DOI: 10.1136/dtb.2024.000007

Main menu